1-20 of 29
Ming-Sound Tsao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer

Eric Winquist, Sebastien J. Hotte, Kim Chi, Srikala Sridhar, Susan Ellard, Michael Ong, Nayyer Iqbal, Muhammad Salim, Urban Emmenegger, Joel R. Gingerich, Aly-Khan Lalani, Pierre Major, Christian Kollmannsberger, Steven Yip, Aaron Hansen, Daygen Finch, Christina Canil, James Hutchenreuther, Francisco Vera-Badillo, Martin Smoragiewicz, Michael Cabanero, Ming-Sound Tsao, Elie Ritch, Alexander W. Wyatt, Lesley Seymour
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (1): 45–55.
https://doi.org/10.1158/1078-0432.CCR-24-1612
Published: 06 January 2025
View article titled, Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer
Open the PDF for Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Challenges to innovation arising from current companion diagnostics regulations and suggestions for improvements

Kelly S. Oliner, Michelle Shiller, Peter Schmid, Marianne J. Ratcliffe, Aaron J. Schetter, Ming-Sound Tsao
Journal: Clinical Cancer Research
Clin Cancer Res (2024)
https://doi.org/10.1158/1078-0432.CCR-24-2729
Published: 26 December 2024
View article titled, Challenges to innovation arising from current companion diagnostics regulations and suggestions for improvements
Open the PDF for Challenges to innovation arising from current companion diagnostics regulations and suggestions for improvements in another window
Journal Articles

Generation of Genetically Engineered Mouse Lung Organoid Models for Squamous Cell Lung Cancers Allows for the Study of Combinatorial Immunotherapy

Josephine Hai, Hua Zhang, Jin Zhou, Zhong Wu, Ting Chen, Eleni Papadopoulos, Catríona M. Dowling, Val Pyon, Yuanwang Pan, Jie Bin Liu, Roderick T. Bronson, Heather Silver, Patrick H. Lizotte, Jiehui Deng, Joshua D. Campbell, Lynette M. Sholl, Christine Ng, Ming-Sound Tsao, Cassandra Thakurdin, Adam J. Bass, Kwok-Kin Wong
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (13): 3431–3442.
https://doi.org/10.1158/1078-0432.CCR-19-1627
Published: 01 July 2020
View article titled, Generation of Genetically Engineered Mouse Lung Organoid Models for Squamous Cell Lung Cancers Allows for the Study of Combinatorial Immunotherapy
Open the PDF for Generation of Genetically Engineered Mouse Lung Organoid Models for Squamous Cell Lung Cancers Allows for the Study of Combinatorial Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86)

Neesha C. Dhani, Hal W. Hirte, Lisa Wang, Julia V. Burnier, Angela Jain, Marcus O. Butler, Stephen Welch, Gini F. Fleming, Jean Hurteau, Koji Matsuo, Daniela Matei, Waldo Jimenez, Carolyn Johnston, Mihaela Cristea, Katia Tonkin, Prafull Ghatage, Stephanie Lheureux, Anjali Mehta, Judy Quintos, Qian Tan, Suzanne Kamel-Reid, Olga Ludkovski, Ming-Sound Tsao, John J. Wright, Amit M. Oza
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (11): 2477–2486.
https://doi.org/10.1158/1078-0432.CCR-19-2576
Published: 01 June 2020
View article titled, Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86)
Open the PDF for Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86) in another window
Includes: Supplementary data
Journal Articles

Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer

Ruoshi Shi, Nikolina Radulovich, Christine Ng, Ni Liu, Hirotsugu Notsuda, Michael Cabanero, Sebastiao N. Martins-Filho, Vibha Raghavan, Quan Li, Arvind Singh Mer, Joshua C. Rosen, Ming Li, Yu-Hui Wang, Laura Tamblyn, Nhu-An Pham, Benjamin Haibe-Kains, Geoffrey Liu, Nadeem Moghal, Ming-Sound Tsao
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (5): 1162–1174.
https://doi.org/10.1158/1078-0432.CCR-19-1376
Published: 02 March 2020
View article titled, Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer
Open the PDF for Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

CD45+CD326+ Cells are Predictive of Poor Prognosis in Non–Small Cell Lung Cancer Patients

Kota Ishizawa, Mie Yamanaka, Yuriko Saiki, Eisaku Miyauchi, Shinichi Fukushige, Tetsuya Akaishi, Atsuko Asao, Takahiro Mimori, Ryota Saito, Yutaka Tojo, Riu Yamashita, Michiaki Abe, Akira Sakurada, Nhu-An Pham, Ming Li, Yoshinori Okada, Tadashi Ishii, Naoto Ishii, Seiichi Kobayashi, Masao Nagasaki, Masakazu Ichinose, Ming-Sound Tsao, Akira Horii
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22): 6756–6763.
https://doi.org/10.1158/1078-0432.CCR-19-0545
Published: 15 November 2019
View article titled, CD45<sup>+</sup>CD326<sup>+</sup> Cells are Predictive of Poor Prognosis in Non–Small Cell Lung Cancer Patients
Open the PDF for CD45<sup>+</sup>CD326<sup>+</sup> Cells are Predictive of Poor Prognosis in Non–Small Cell Lung Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Targeting the CDK4/6-Rb Pathway Enhances Response to PI3K Inhibition in PIK3CA-Mutant Lung Squamous Cell Carcinoma

Ruoshi Shi, Ming Li, Vibha Raghavan, Shirley Tam, Michael Cabanero, Nhu-An Pham, Frances A. Shepherd, Nadeem Moghal, Ming-Sound Tsao
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (23): 5990–6000.
https://doi.org/10.1158/1078-0432.CCR-18-0717
Published: 03 December 2018
View article titled, Targeting the CDK4/6-Rb Pathway Enhances Response to PI3K Inhibition in <em>PIK3CA</em>-Mutant Lung Squamous Cell Carcinoma
Open the PDF for Targeting the CDK4/6-Rb Pathway Enhances Response to PI3K Inhibition in <em>PIK3CA</em>-Mutant Lung Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Synergy of WEE1 and mTOR Inhibition in Mutant KRAS-Driven Lung Cancers

Josephine Hai, Shengwu Liu, Lauren Bufe, Khanh Do, Ting Chen, Xiaoen Wang, Christine Ng, Shuai Li, Ming-Sound Tsao, Geoffrey I. Shapiro, Kwok-Kin Wong
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (22): 6993–7005.
https://doi.org/10.1158/1078-0432.CCR-17-1098
Published: 14 November 2017
View article titled, Synergy of WEE1 and mTOR Inhibition in Mutant <em>KRAS</em>-Driven Lung Cancers
Open the PDF for Synergy of WEE1 and mTOR Inhibition in Mutant <em>KRAS</em>-Driven Lung Cancers in another window
Includes: Supplementary data
Journal Articles

BRM Promoter Polymorphisms and Survival of Advanced Non–Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 Trial

Geoffrey Liu, Sinead Cuffe, Shermi Liang, Abul Kalam Azad, Lu Cheng, Yonathan Brhane, Xin Qiu, David W. Cescon, Jeffrey Bruce, Zhuo Chen, Dangxiao Cheng, Devalben Patel, Brandon C. Tse, Scott A. Laurie, Glenwood Goss, Natasha B. Leighl, Rayjean Hung, Penelope A. Bradbury, Lesley Seymour, Frances A. Shepherd, Ming Sound Tsao, Bingshu E. Chen, Wei Xu, David N. Reisman
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (10): 2460–2470.
https://doi.org/10.1158/1078-0432.CCR-16-1640
Published: 14 May 2017
View article titled, BRM Promoter Polymorphisms and Survival of Advanced Non–Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 Trial
Open the PDF for BRM Promoter Polymorphisms and Survival of Advanced Non–Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 Trial in another window
Includes: Supplementary data
Journal Articles

Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma

Licun Wu, Ghassan Allo, Thomas John, Ming Li, Tetsuzo Tagawa, Isabelle Opitz, Masaki Anraku, Zhihong Yun, Melania Pintilie, Bethany Pitcher, Geoffrey Liu, Ron Feld, Michael R. Johnston, Marc de Perrot, Ming-Sound Tsao
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (4): 1060–1067.
https://doi.org/10.1158/1078-0432.CCR-16-0844
Published: 14 February 2017
View article titled, Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma
Open the PDF for Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma in another window
Includes: Supplementary data
Journal Articles

Abstract B31: Establishment and molecular characterization of patient-derived tumor xenografts from resected tumors or ascites fluids of patients with pancreatic/ampullary/bile duct carcinomas

Nikolina Radulovich, Emin Ibrahimov, Carson Holt, Vibha Raghavan, Tracy Zhao, Rob Denroch, Nhu-An Pham, Steve Gallinger, Melania Pintilie, Lincoln Stein, John McPherson, Lakshmi Muthuswamy, Ming Sound Tsao
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (16_Supplement): B31.
https://doi.org/10.1158/1557-3265.PDX16-B31
Published: 15 August 2016
View article titled, Abstract B31: Establishment and molecular characterization of patient-derived tumor xenografts from resected tumors or ascites fluids of patients with pancreatic/ampullary/bile duct carcinomas
Journal Articles

Abstract B32: Fidelity of genomic and proteomic features of patient-derived xenografts of lung cancers

Nhu-An Pham, Dennis Wang, Jiefei Tong, Chang-Qi Zhu, Lei Li, Wen Zhang, Ruoshi Shi, Shingo Sakashita, Melania Pintilie, Michael F. Moran, Geoffrey Liu, Ming-Sound Tsao
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (16_Supplement): B32.
https://doi.org/10.1158/1557-3265.PDX16-B32
Published: 15 August 2016
View article titled, Abstract B32: Fidelity of genomic and proteomic features of patient-derived xenografts of lung cancers
Journal Articles

Abstract PR03: Molecular profiling of advanced solid tumors at Princess Margaret Cancer Centre and patient outcomes with genotype-matched clinical trials

Philippe L. Bedard, Amit Oza, Blaise Clarke, Ming-Sound Tsao, Natasha B. Leighl, Eric X. Chen, Albiruni Razak, Hal K. Berman, Stefano Serra, Michael Roehrl, Nadia Califaretti, Mateya Trinkaus, Tong Zhang, Mahadeo A. Sukhai, Anca Milea, Aaron R. Hansen, Trevor J. Pugh, Tracy Stockley, Suzanne Kamel-Reid, Lillian L. Siu
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (1_Supplement): PR03.
https://doi.org/10.1158/1557-3265.PMSCLINGEN15-PR03
Published: 03 January 2016
View article titled, Abstract PR03: Molecular profiling of advanced solid tumors at Princess Margaret Cancer Centre and patient outcomes with genotype-matched clinical trials
Journal Articles

NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma

David W. Cescon, Desmond She, Shingo Sakashita, Chang-Qi Zhu, Melania Pintilie, Frances A. Shepherd, Ming-Sound Tsao
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (11): 2499–2505.
https://doi.org/10.1158/1078-0432.CCR-14-2206
Published: 31 May 2015
View article titled, NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma
Open the PDF for NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Integrating RAS Status into Prognostic Signatures for Adenocarcinomas of the Lung

Maud HW. Starmans, Melania Pintilie, Michelle Chan-Seng-Yue, Nathalie C. Moon, Syed Haider, Francis Nguyen, Suzanne K. Lau, Ni Liu, Arek Kasprzyk, Bradly G. Wouters, Sandy D. Der, Frances A. Shepherd, Igor Jurisica, Linda Z. Penn, Ming-Sound Tsao, Philippe Lambin, Paul C. Boutros
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2015) 21 (6): 1477–1486.
https://doi.org/10.1158/1078-0432.CCR-14-1749
Published: 12 March 2015
View article titled, Integrating RAS Status into Prognostic Signatures for Adenocarcinomas of the Lung
Open the PDF for Integrating RAS Status into Prognostic Signatures for Adenocarcinomas of the Lung in another window
Includes: Supplementary data
Journal Articles

Abstract IA10: Molecular testing to personalized EGFR and ALK inhibitor therapies in lung cancer.

Ming Sound Tsao
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (2_Supplement): IA10.
https://doi.org/10.1158/1078-0432.14AACRIASLC-IA10
Published: 16 January 2014
View article titled, Abstract IA10: Molecular testing to personalized EGFR and ALK inhibitor therapies in lung cancer.
Journal Articles

L1 Cell Adhesion Molecule Promotes Tumorigenicity and Metastatic Potential in Non–Small Cell Lung Cancer

Josephine Hai, Chang-Qi Zhu, Bizhan Bandarchi, Yu-Hui Wang, Roya Navab, Frances A. Shepherd, Igor Jurisica, Ming-Sound Tsao
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (7): 1914–1924.
https://doi.org/10.1158/1078-0432.CCR-11-2893
Published: 01 April 2012
View article titled, L1 Cell Adhesion Molecule Promotes Tumorigenicity and Metastatic Potential in Non–Small Cell Lung Cancer
Open the PDF for L1 Cell Adhesion Molecule Promotes Tumorigenicity and Metastatic Potential in Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract B34: Overcoming resistance to EGFR-Tyrosine Kinase Inhibitor therapy in non-small cell lung cancer

Rafael Sierra, Anderson Chang, Jason Moffat, Benjamin G. Neel, Ming-Sound Tsao
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (3_Supplement): B34.
https://doi.org/10.1158/1078-0432.12AACRIASLC-B34
Published: 01 February 2012
View article titled, Abstract B34: Overcoming resistance to EGFR-Tyrosine Kinase Inhibitor therapy in non-small cell lung cancer
Open the PDF for Abstract B34: Overcoming resistance to EGFR-Tyrosine Kinase Inhibitor therapy in non-small cell lung cancer in another window
Journal Articles

Abstract A29: Genomic alteration of E2F/Rb activates EZH2 in small cell lung cancer

Kelsie L. Thu, Roland Hubaux, Sarit Aviel-Ronen, Calum E. MacAulay, Ming-Sound Tsao, Stephen Lam, Wan L. Lam, Bradley P. Coe
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (3_Supplement): A29.
https://doi.org/10.1158/1078-0432.12AACRIASLC-A29
Published: 01 February 2012
View article titled, Abstract A29: Genomic alteration of E2F/Rb activates EZH2 in small cell lung cancer
Open the PDF for Abstract A29: Genomic alteration of E2F/Rb activates EZH2 in small cell lung cancer in another window
Journal Articles

The Ability to Form Primary Tumor Xenografts Is Predictive of Increased Risk of Disease Recurrence in Early-Stage Non–Small Cell Lung Cancer

Thomas John, Derek Kohler, Melania Pintilie, Naoki Yanagawa, Nhu-An Pham, Ming Li, Devang Panchal, Frances Hui, Fannong Meng, Frances A. Shepherd, Ming-Sound Tsao
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (1): 134–141.
https://doi.org/10.1158/1078-0432.CCR-10-2224
Published: 04 January 2011
View article titled, The Ability to Form Primary Tumor Xenografts Is Predictive of Increased Risk of Disease Recurrence in Early-Stage Non–Small Cell Lung Cancer
Open the PDF for The Ability to Form Primary Tumor Xenografts Is Predictive of Increased Risk of Disease Recurrence in Early-Stage Non–Small Cell Lung Cancer in another window